VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HSICHenry Schein, Inc.
$79.92$9.2B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHSICP/E History

HSIC logoHenry Schein, Inc. (HSIC) P/E Ratio History

Fairly Valued

Trading at 24.5x, near 5Y avg of 21.6x · 90th percentile · In line with own history · Data 1996–2025

Current P/E (TTM)
24.5x
+13% vs 5Y avg
5Y Avg P/E
21.6x
Median 22.3x
5Y Percentile
90th
Upper end of range
PEG Ratio
7.76
Premium to growth
5-Year P/E Range
24.5x
Min14.7xMedian22.3xMax30.0x
TTM EPS$3.36
Price$79.97
Earnings Yield4.09%
EPS Growth (1Y)7.2%
EPS Growth (5Y)3.2%

Loading P/E history...

P/E Ratio Analysis

As of June 20, 2026, Henry Schein, Inc. (HSIC) trades at a price-to-earnings ratio of 24.5x, with a stock price of $79.97 and trailing twelve-month earnings per share of $3.36.

The current P/E is 13% above its 5-year average of 21.6x. Over the past five years, HSIC's P/E has ranged from a low of 14.7x to a high of 30.0x, placing the current valuation at the 90th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.2x, HSIC is roughly in line with its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 196.0x.

The PEG ratio of 7.76 (P/E divided by 7% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, HSIC trades roughly in line with the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HSIC DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

HSIC Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
24.5vs22.2
+10%
Above Sector
vs. S&P 500
24.5vs24.4
+0%
In Line with Market
PEG Analysis
7.76
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 7% EPS growth (1Y)

HSIC P/E vs Peers

Dental and Office-Based Distribution peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
DXPE logoDXPEDXP Enterprises, Inc.
$3B30.8-+27%
MCK logoMCKMcKesson Corporation
$94B20.3-+49%
CAH logoCAHCardinal Health, Inc.
$53B35.1-+87%
ALGN logoALGNAlign Technology, Inc.
$12B30.7-+1%
NVST logoNVSTEnvista Holdings Corp
$4B88.859.46+104%
GMED logoGMEDGlobus Medical, Inc.
$10B19.2Lowest0.62Best+423%Best
SYK logoSYKStryker Corporation
$115B35.92.41+8%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

HSIC Historical P/E Data (1996–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2025 Q4Dec 27 2025$76.13$3.2723.3x-79%
FY2025 Q3Sep 27 2025$66.06$3.1620.9x-81%
FY2025 Q2Jun 28 2025$73.27$3.1023.6x-79%
FY2025 Q1Mar 29 2025$68.62$3.2021.4x-81%
FY2024 Q4-$69.20$3.0422.8x-79%
FY2024 Q3Sep 28 2024$73.22$2.4430.0x-73%
FY2024 Q2Jun 29 2024$64.10$2.7123.7x-79%
FY2024 Q1Mar 30 2024$75.52$2.9725.4x-77%
FY2023 Q4Dec 31 2023$75.71$3.1624.0x-78%
FY2023 Q3Sep 30 2023$74.25$3.3722.0x-80%
FY2023 Q2Jul 01 2023$81.10$3.4123.8x-78%
FY2023 Q1Apr 01 2023$81.54$3.5023.3x-79%
FY2022 Q4Dec 31 2022$79.87$3.8920.5x-81%
FY2022 Q3Sep 24 2022$67.34$4.5914.7x-87%
FY2022 Q2Jun 25 2022$77.29$4.6016.8x-85%
FY2022 Q1Mar 26 2022$87.85$4.5519.3x-83%
FY2021 Q4Dec 31 2021$77.53$4.4117.6x-84%
FY2021 Q3Sep 25 2021$78.10$4.3418.0x-84%
FY2021 Q2Jun 26 2021$75.01$4.2317.7x-84%
FY2021 Q1Mar 27 2021$67.98$3.0522.3x-80%
FY2020 Q4-$66.86$2.8023.8x-78%
FY2020 Q3Sep 26 2020$58.79$4.0614.5x-87%
FY2020 Q2Jun 27 2020$56.67$4.0214.1x-87%
FY2020 Q1Mar 28 2020$50.00$4.8710.3x-91%
FY2019 Q4-$66.72$4.6914.2x-87%
FY2019 Q3Sep 28 2019$62.58$3.3218.8x-83%
FY2019 Q2Jun 29 2019$69.90$3.1622.1x-80%
FY2019 Q1Mar 30 2019$60.11$3.3118.2x-84%
FY2018 Q4Dec 31 2018$61.58$3.4917.6x-84%
FY2018 Q3Sep 29 2018$66.69$2.5626.0x-76%
FY2018 Q2Jun 30 2018$56.97$2.6521.5x-81%
FY2018 Q1Mar 31 2018$52.71$2.5820.4x-82%
FY2017 Q4Dec 31 2017$54.81$2.5621.5x-81%
FY2017 Q3Sep 30 2017$64.31$3.4818.5x-83%
FY2017 Q2Jun 30 2017$71.77$3.4320.9x-81%
FY2017 Q1Mar 31 2017$66.65$3.3020.2x-82%
FY2016 Q4Dec 31 2016$59.49$3.1119.1x-83%
FY2016 Q3Sep 30 2016$63.91$3.0221.2x-81%
FY2016 Q2-$69.33$2.9623.4x-79%
FY2016 Q1Mar 26 2016$65.87$2.9322.5x-80%
FY2015 Q4-$62.04$2.8521.8x-80%
FY2015 Q3Sep 26 2015$51.42$2.8518.0x-84%
FY2015 Q2Jun 27 2015$57.04$2.7620.7x-81%
FY2015 Q1Mar 28 2015$54.43$2.7419.9x-82%
FY2014 Q4Dec 31 2014$53.39$2.7219.6x-82%
FY2014 Q3Sep 27 2014$45.93$2.6617.3x-84%
FY2014 Q2Jun 28 2014$46.61$2.6117.9x-84%
FY2014 Q1Mar 29 2014$46.18$2.5518.1x-84%
FY2013 Q4-$44.81$2.4818.1x-84%
FY2013 Q3Sep 28 2013$40.58$2.3917.0x-85%
FY2013 Q2Jun 29 2013$37.55$2.3116.3x-85%
FY2013 Q1Mar 30 2013$36.29$2.2316.3x-85%
FY2012 Q4Dec 31 2012$31.54$2.1614.6x-87%
FY2012 Q3Sep 29 2012$31.07$2.1014.8x-87%
FY2012 Q2Jun 30 2012$30.78$2.0614.9x-86%
FY2012 Q1Mar 31 2012$29.68$2.0314.6x-87%
FY2011 Q4Dec 31 2011$25.27$1.9912.7x-89%
FY2011 Q3Sep 24 2011$24.55$1.9212.8x-88%
FY2011 Q2Jun 25 2011$27.26$1.8914.4x-87%
FY2011 Q1Mar 26 2011$26.45$1.8314.5x-87%
FY2010 Q4Dec 31 2010$24.07$1.7513.8x-88%
FY2010 Q3Sep 25 2010$22.48$1.7213.1x-88%
FY2010 Q2Jun 26 2010$21.85$1.7812.3x-89%
FY2010 Q1Mar 27 2010$22.67$1.7413.0x-88%
FY2009 Q4-$20.63$1.7212.0x-89%
FY2009 Q3Sep 26 2009$21.47$1.5613.8x-88%
FY2009 Q2Jun 27 2009$18.63$1.4013.3x-88%
FY2009 Q1Mar 28 2009$15.69$1.3411.7x-89%
FY2008 Q4Dec 31 2008$14.39$1.3111.0x-90%
FY2008 Q3Sep 27 2008$21.49$1.4315.0x-86%
FY2008 Q2Jun 28 2008$20.16$1.3914.5x-87%
FY2008 Q1Mar 29 2008$22.23$1.2318.1x-84%
FY2007 Q4Dec 31 2007$24.08$1.1920.2x-82%
FY2007 Q3Sep 29 2007$23.86$1.1121.5x-81%
FY2007 Q2Jun 30 2007$20.95$1.0021.0x-81%
FY2007 Q1Mar 31 2007$21.64$1.0620.4x-82%
FY2006 Q4Dec 31 2006$19.21$0.9121.1x-81%
FY2006 Q3Sep 30 2006$19.66$0.8523.1x-79%
FY2006 Q2Jul 01 2006$18.33$0.7624.1x-78%
FY2006 Q1Apr 01 2006$18.77$0.7226.1x-76%
FY2005 Q4Dec 31 2005$17.11$0.8121.1x-81%
FY2005 Q3Sep 24 2005$16.84$0.6924.4x-78%
FY2005 Q2Jun 25 2005$16.26$0.7422.0x-80%
FY2005 Q1Mar 26 2005$14.12$0.7518.8x-83%
FY2004 Q4Dec 31 2004$13.65$0.7318.7x-83%
FY2004 Q3Sep 25 2004$11.95$0.7615.7x-86%
FY2004 Q2Jun 26 2004$12.66$0.8315.3x-86%
FY2004 Q1Mar 27 2004$13.66$0.8017.1x-85%
FY2003 Q4Dec 31 2003$13.27$0.7817.0x-85%
FY2003 Q3Sep 27 2003$10.96$0.7514.6x-87%
FY2003 Q2Jun 28 2003$10.35$0.7214.4x-87%
FY2003 Q1Mar 29 2003$8.89$0.6912.9x-88%
FY2002 Q4-$8.82$0.6114.6x-87%
FY2002 Q3Sep 28 2002$10.44$0.5220.2x-82%
FY2002 Q2Jun 29 2002$8.73$0.3723.6x-79%
FY2002 Q1Mar 30 2002$8.64$0.2731.9x-71%
FY2001 Q4Dec 31 2001$7.26$0.2628.3x-74%
FY2001 Q3Sep 29 2001$7.57$0.2135.4x-68%
FY2001 Q2Jun 30 2001$7.50$0.1940.0x-64%
FY2001 Q1Mar 31 2001$7.21$0.1841.2x-63%
FY2000 Q4Dec 31 2000$6.79$0.1740.2x-64%
FY2000 Q3Sep 23 2000$3.64$0.1425.3x-77%
FY2000 Q2Jun 24 2000$3.31$0.1131.4x-72%
FY2000 Q1Mar 25 2000$3.36$0.0750.0x-55%
FY1999 Q4Dec 31 1999$2.61$0.0465.1x-41%
FY1999 Q3Sep 25 1999$2.84$0.03102.3x-7%
FY1999 Q2Jun 26 1999$5.98$0.02293.2x+165%
FY1999 Q1Mar 27 1999$4.91$0.02307.1x+178%
FY1998 Q4-$8.77$0.01675.0x+511%
FY1998 Q3Sep 26 1998$6.83$0.01498.2x+351%
FY1998 Q2Jun 27 1998$9.02$0.002147.5x+1842%
FY1998 Q1Mar 28 1998$7.57$0.003442.5x+3014%
FY1997 Q3Sep 27 1997$6.96$0.001988.8x+1699%
FY1997 Q2Jun 28 1997$5.99$0.02389.1x+252%
FY1997 Q1Mar 29 1997$5.71$0.01393.8x+256%
FY1996 Q4-$6.74$0.02434.9x+293%

Average P/E for displayed period: 110.6x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

30+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HSIC — Frequently Asked Questions

Quick answers to the most common questions about buying HSIC stock.

What is HSIC's P/E ratio?

Henry Schein, Inc. (HSIC) trailing twelve-month P/E ratio is 24.5x, based on TTM diluted EPS of $3.36. The 5-year average P/E is 21.6x and the historical range spans 14.7x to 30.0x.

Is HSIC stock overvalued or undervalued?

HSIC trades at 24.5x P/E, near its 5-year average of 21.6x. The 90th percentile ranking within the 14.7x–30.0x historical range places valuation within normal bounds.

Is HSIC stock expensive?

HSIC is fairly valued relative to its own history. The current P/E of 24.5x is near the 5-year average of 21.6x (90th percentile of historical range).

What is HSIC's historical P/E range?

Over the past 5 years, HSIC's P/E ratio has ranged from 14.7x to 30.0x, with a median of 22.3x and an average of 21.6x. The current P/E of 24.5x places the stock at the 90th percentile of this range. Full historical data spans 1996–2025.

How does HSIC's P/E compare to the S&P 500?

HSIC trades at 24.5x P/E versus the S&P 500 median of 24.4x. The 0% premium to the market typically reflects higher expected earnings growth or quality.

How does HSIC's valuation compare to Healthcare peers?

Henry Schein, Inc. P/E of 24.5x compares to the Healthcare sector median of 22.2x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is HSIC's PEG ratio?

HSIC PEG ratio is 7.76, based on a P/E of 24.5x and EPS growth of 7.2%. A PEG above 2.0 indicates a premium valuation relative to earnings growth — typically considered expensive.

What is HSIC's earnings yield?

HSIC earnings yield is 4.09%, the inverse of its 24.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

HSIC P/E Ratio History (1996–2025)

Quarterly valuation multiple from closing price and trailing EPS

Current23.3x
Period Avg21.6x
Range14.7x - 30.0x
Change+5%
20 quartersMar 27, 2021 - Dec 27, 2025